Enrolling Studies

  • HVTN 302 phase 1, randomized, open-label clinical trial to evaluate the safety and immunogenicity of 3 study vaccines is made using messenger ribonucleic acid (mRNA) technology developed by Moderna, Inc. mRNA is a piece of genetic code carried into your body by the vaccine as a message with instructions in the same way that the mRNA vaccines against COVID instruct the body’s cells to make the SARS-CoV-2 spike protein. Instead of showing your immune system actual pieces of HIV, the study vaccines carry instructions that show human muscle cells how to make small pieces that look like parts of HIV
  • Gilead Lenacapivir  A Phase 1, Open-Label, Single-Arm, Single-Dose Study to Evaluate the Pharmacokinetics and Distribution of Long-Acting HIV Capsid Inhibitor, Lenacapavir (LEN)  The purpose of this study is to measure the amount of LEN in blood and how long it takes the body to get rid of it, to evaluate the safety and tolerability of single injection doses of subcutaneous LEN, and to measure the amount of LEN in rectal, cervical and/or vaginal tissues